For the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

For the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who have an inadequate response to treatment with beta-blockers or prostaglandin analogues.

For the treatment of the symptoms of seasonal allergic conjunctivitis.

For the treatment of corneal ulcers of various etiologies, corneal injuries, acid- or alkali-induced corneal burns, bullous keratopathy, neuroparalytic keratitis, and degenerative disorders of the cornea and conjunctiva.